NCT07412613
- Conditions
- MSI-H/dMMR Colorectal Cancer, Resectable Colon Cancer
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, China
Clinical trial condition
MSI-H/dMMR Colorectal Cancer
Explore clinical trials studying MSI-H/dMMR Colorectal Cancer. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
MSI-H/dMMR Colorectal Cancer trial results
- Conditions
- Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
- Locations
-
- Morristown Medical Center Morristown, New Jersey, United States
- Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
- GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
Not Yet Recruiting
QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC
NCT07009145
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +11 more
- Locations
-
- The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China